Atlas FDA

Amplatzer Amulet (ACP2)

FDA premarket approval P200049/S005 · decided 2023-05-02

Approval details

PMA number
P200049
Supplement
S005
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Amplatzer Amulet (ACP2)
Generic name
System, appendage closure, left atrial
Applicant
ABBOTT MEDICAL
Date received
2023-04-05
Decision date
2023-05-02
Days to decision
27 days
Decision code
OK30
Product code
NGV
Advisory committee
Cardiovascular
Expedited review
No
Location
St. Paul, MN
Statement
Addition of two (2) sterilization chambers at the Steris Costa Rica facility to sterilize the subject devices.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18